CPPD Haemochromatosis Screen — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Screen for haemochromatosis (ferritin transferrin saturation) as this combination is classic for haemochromatosis arthropathy
The best answer is “Screen for haemochromatosis (ferritin transferrin saturation) as this combination is classic for haemochromatosis arthropathy”. Screen for haemochromatosis (ferritin transferrin saturation) as this combination is classic for haemochromatosis arthropathy is supported by the cited UK or directly applicable specialist authority and best matches the tested threshold, complication or monitoring principle. The remaining choices—“principally urate, with clinical reassessment, with clinical reassessment, within a rheumatology pathway, after safety review”, “No investigation, within a rheumatology pathway, within a rheumatology pathway, after safety review, after specialist assessment”, “Assume primary OA, after safety review, after safety review, after specialist assessment, with clinical reassessment”, “Thyroid principally, after specialist assessment, after specialist assessment, with clinical reassessment, within a rheumatology pathway”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.
Reference: NICE NG219 gout: https://www.nice.org.uk/guidance/ng219/chapter/Recommendations